MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Addressing Sex and Gender Gaps in Parkinson’s Research: A Multi-Stakeholder Approach

L. Smith, S. Hussain-Ali, R. Flanagan, C. Carroll, M. Auffret (London, United Kingdom)

Meeting: 2025 International Congress

Keywords: Parkinson’s

Category: Parkinson's Disease (Other)

Objective: To describe and address sex and gender gaps in Parkinson’s disease (PD) research through a multidisciplinary, multi-stakeholder approach that includes patient representatives, researchers, clinicians, and funding bodies.

Background: Despite evidence that PD prevalence, symptoms, and treatment responses differ between sexes, women remain underrepresented in PD research. The extrapolation of male-dominated study results to women can lead to adverse effects and suboptimal care. Hormonal influences—such as those related to menstrual cycles, pregnancy, and menopause—are poorly understood, and clinical trials often overlook sex- and gender-specific barriers, including caregiving responsibilities and accessibility challenges. Addressing these gaps is critical to advancing personalized and equitable treatments.

Method: On International Women’s Day 2025, Cure Parkinson’s and Parkinson’s UK hosted a panel discussion and webinar with 80 researchers, clinicians, people with PD, and charity stakeholders to explore why sex and gender gaps exist in PD research, how they can be addressed, and the barriers and facilitators to implementation. Key themes were extracted from discussions, contextualized with research literature and policy, and synthesized into a position paper outlining targeted actions.

Results: Key recommendations include:

Researchers

-Co-design clinical studies with women with PD, ensuring clinical trials accommodate barriers to participation, such as caregiving and accessibility challenges

-Mandated sex- and gender-disaggregated data reporting (including pharmacokinetics)

-Integrate female models in preclinical studies

Clinicians

-Consider hormonal influences on PD symptoms

-Adopt a more holistic approach to care

Charities and Funders

-Ensure research funding prioritizes sex- and gender-inclusive studies

-Develop information and training resources on sex differences in PD

Women with PD

-Engage in research

-Self-advocate for improved representation and care.

Conclusion: A multi-stakeholder approach is essential to addressing sex and gender disparities in PD research and care. Implementing these actions will enhance understanding of disease differences, facilitate tailored interventions, and ultimately improve patient care for all individuals with PD.

To cite this abstract in AMA style:

L. Smith, S. Hussain-Ali, R. Flanagan, C. Carroll, M. Auffret. Addressing Sex and Gender Gaps in Parkinson’s Research: A Multi-Stakeholder Approach [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/addressing-sex-and-gender-gaps-in-parkinsons-research-a-multi-stakeholder-approach/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/addressing-sex-and-gender-gaps-in-parkinsons-research-a-multi-stakeholder-approach/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley